TWi Biotechnology, Inc.

Quick facts

Phase 2 pipeline

• AC-201
• AC-201CR
• AC-203 · Pain
  AC-203 is a selective agonist of the kappa opioid receptor.
• AC-701 Topical Gel 0.3%

Phase 1 pipeline

• AC-1101

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• TWi Biotechnology, Inc. portfolio CI brief
• TWi Biotechnology, Inc. pipeline updates RSS